Apoptosis-inducing proteins with reduced expression in breast cancer: A review article
Open Access
- 5 February 2025
- journal article
- review article
- Published by Elsevier in Biochemistry and Biophysics Reports
- Vol. 41, 101931
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Molecular insights into the anti-cancer activity of chitosan-okra mucilage polymeric nanocomposite doped with nano zero-valent iron against multi-drug-resistant oral carcinoma cellsInternational Journal of Biological Macromolecules, 2024
- Targeting cyclin-dependent kinase 2 CDK2: Insights from molecular docking and dynamics simulation – A systematic computational approach to discover novel cancer therapeuticsComputational Biology and Chemistry, 2024
- Current and future burden of breast cancer: Global statistics for 2020 and 2040The Breast, 2022
- A novel chimeric protein with enhanced cytotoxic effects on breast cancer in vitro and in vivoProteins: Structure, Function, and Bioinformatics, 2021
- Gum acacia PEG iron oxide nanocomposite (GA-PEG-IONC) induced pharmacotherapeutic activity on the Las R gene expression of Pseudomonas aeruginosa and HOXB13 expression of prostate cancer (Pc 3) cell line. A green therapeutic approach of molecular mechanism inhibitionInternational Journal of Biological Macromolecules, 2021
- DFF40-iRGD, a novel chimeric protein with efficient cytotoxic and apoptotic effects against triple-negative breast cancer cellsBiotechnology Letters, 2021
- Alternative splicing is an important mechanism behind KAI1 loss of function in breast cancer patients from Saudi ArabiaBreast Cancer Research and Treatment, 2018
- rApoptin induces apoptosis in human breast cancer cells via phosphorylation of Nur77 and AktBiochemical and Biophysical Research Communications, 2018
- Stable overexpression of DNA fragmentation factor in T-47D cells: sensitization of breast cancer cells to apoptosis in response to acetazolamide and sulfabenzamideMolecular Biology Reports, 2014
- KAI1/CD82 is a novel target of estrogen receptor‐mediated gene repression and downregulated in primary human breast cancerInternational Journal of Cancer, 2008